Clinical Study of Lamotrigine to Treat Newly Diagnosed Typical Absence Seizure in Children and Adolescents

PHASE3CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

September 30, 2011

Primary Completion Date

February 28, 2014

Study Completion Date

November 30, 2015

Conditions
Epilepsy
Interventions
DRUG

Lamictal

No comparison

Trial Locations (14)

453-8511

GSK Investigational Site, Aichi

790-8524

GSK Investigational Site, Ehime

791-0295

GSK Investigational Site, Ehime

807-8555

GSK Investigational Site, Fukuoka

814-0180

GSK Investigational Site, Fukuoka

730-8518

GSK Investigational Site, Hiroshima

006-0041

GSK Investigational Site, Hokkaido

060-8648

GSK Investigational Site, Hokkaido

232-8555

GSK Investigational Site, Kanagawa

950-2085

GSK Investigational Site, Niigata

700-8558

GSK Investigational Site, Okayama

430-8558

GSK Investigational Site, Shizuoka

113-8603

GSK Investigational Site, Tokyo

120-752

GSK Investigational Site, Seoul

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY